Megestrol: all 86 studies that test it
Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and ImmunotherapyNot yet recruitingNCT07565415Phase 2
- Megestrol Acetate for Fatigue Management in T-DXd Treated Breast CancerRecruitingNCT07543536Phase 3
- Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular CarcinomaNot yet recruitingNCT07356037Phase 3
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingNCT07319429Phase 2/3
- A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer PatientsNot yet recruitingNCT07254416Phase 4
- A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer CachexiaRecruitingNCT07243379Phase 4
- Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerRecruitingNCT07150663Phase 3
- Nano-crystalline Megestrol Acetate for Anorexia-Cachexia Syndrome in Advanced Lung CancerNot yet recruitingNCT07092137Phase 2
- Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRCRecruitingNCT06998758Phase 3
- A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)RecruitingNCT06979596Phase 2
- Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia PhaseNot yet recruitingNCT06961201Phase 3
- Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology AnalysisNot yet recruitingNCT06961188Phase 3
- Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical StudyNot yet recruitingNCT06909383Phase 2
- Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related FatigueRecruitingNCT06830018Not applicable
- Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.Not yet recruitingNCT06772428Phase 3
- Nutrition Impact on Immunotherapy of CancerRecruitingNCT06500234Phase 3
- Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age WomenRecruitingNCT06417736Not applicable
- Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)RecruitingNCT05913427Phase 2
- Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical HyperplasiaRecruitingNCT05316493Phase 2/3
- Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral ContraceptiveTerminatedNCT05264506Phase 3Results posted
- iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in ChildrenCompletedNCT03815019Phase 4Results posted
- Phenytoin for Memory Impairment Secondary to MegestrolCompletedNCT02595723Phase 4Results posted
- Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial AdenocarcinomaCompletedNCT01968317Phase 2Results posted
- A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)CompletedNCT01709318Phase 2Results posted
- Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)TerminatedNCT01656434Phase 3Results posted
- Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328)CompletedNCT01345786Phase 1Results posted
- Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or ChemotherapyTerminatedNCT01200602Phase 2Results posted
- Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial CancerCompletedNCT00729586Phase 2Results posted
- Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated SuspensionTerminatedNCT00637806Phase 3Results posted
- Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer PatientsTerminatedNCT00637728Phase 3Results posted
- Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight LossCompletedNCT00637572Phase 2Results posted
- A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine CancerCompletedNCT00584857Phase 2Results posted
- Adrenal Suppression and Adrenal Recovery Induced by Megestrol AcetateCompletedNCT00575029Not applicableResults posted
- Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)CompletedNCT00511433Phase 3Results posted
- Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)CompletedNCT00511355Phase 3Results posted
- Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)CompletedNCT00511342Phase 3Results posted
- Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)CompletedNCT00511199Phase 3Results posted
- Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial HyperplasiaTerminatedNCT00503581Phase 2Results posted
- Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol AcetateCompletedNCT00483327Phase 2Results posted
- Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)CompletedNCT00413062Phase 3Results posted
- The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial PreparationCompletedNCT06324851Phase 4
- A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in SingaporeStatus unknownNCT05492487Phase 2
- Study of Megestrol Acetate in Grade 2 Endometrioid Endometrial CancerTerminatedNCT05332483Phase 1
- Weight Management Plus Megestrol Acetate in Early-stage Endometrioid CarcinomaTerminatedNCT05316467Phase 2/3
- Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial HyperplasiaTerminatedNCT04607252Phase 2/3
- Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial HyperplasiaCompletedNCT04491682Phase 2/3
- Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial CarcinomaCompletedNCT04491643Phase 2
- the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic ChemotherapyStatus unknownNCT04430361Phase 2
- Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western MedicineCompletedNCT03963752Phase 4
- The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With MegestrolStatus unknownNCT03777930Phase 4
- Comparison of Coagulation Profiles Between Zoely and Minidoz: RCTTerminatedNCT03531437Phase 4
- A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast CancerCompletedNCT03306472Phase 2
- Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical HyperplasiaCompletedNCT03241888Phase 2/3
- Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal ContraceptionCompletedNCT03077555Phase 4
- A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast CancerStatus unknownNCT03024580Phase 2
- Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRTStatus unknownNCT02980653Phase 2
- Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial CancerWithdrawnNCT01943058Phase 2
- Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)WithdrawnNCT01723579Phase 3
- A New Treatment Option for Heavy Menstrual BleedingStatus unknownNCT01715025Phase 4
- Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary SyndromeStatus unknownNCT01603745Phase 1
- Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed ConditionCompletedNCT01589562Phase 1
- A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed ConditionStatus unknownNCT01383330Phase 1
- Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving EstradiolCompletedNCT01361958Phase 2
- A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)CompletedNCT00711607Phase 1
- Evaluating the Effect of Food on Absorption of Megace ESCompletedNCT00638079Phase 1
- Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated SuspensionTerminatedNCT00637403Phase 1
- Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of WeightCompletedNCT00507949Phase 2
- Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia PatientsTerminatedNCT00503516Phase 2/3
- Pharmacokinetics and Safety of Transdermal Megestrol AcetateWithdrawnNCT00163072Phase 4
- Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for CancerCompletedNCT00070148Phase 3
- Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentCompletedNCT00066248Phase 2
- Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00041275Phase 3
- Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung CancerCompletedNCT00031785Phase 3
- Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of AppetiteCompletedNCT00031707Phase 3
- Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerTerminatedNCT00016341Phase 3
- Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck CancerCompletedNCT00006799Phase 3
- S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast CancerCompletedNCT00005975Phase 3
- Megestrol and Exercise in Treating Patients With Cancer-Related Weight LossCompletedNCT00004912Phase 2
- Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-WastingCompletedNCT00004664Not applicable
- High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or MesotheliomaStatus unknownNCT00002465Phase 1/2
- The Safety and Effectiveness of Megace in HIV-Infected WomenCompletedNCT00002345Phase 4
- A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and MalnutritionCompletedNCT00002300Phase 2
- A Study of Megestrol Acetate in HIV-Infected ChildrenCompletedNCT00002182Not applicable
- A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and CachexiaCompletedNCT00002067Phase 3
- A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight LossCompletedNCT00001079Phase 2
- A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting SyndromeCompletedNCT00000737Phase 1